Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Canadian Family Physician Medecin De Famille Canadien
|
October 14, 2022
Sodium-glucose cotransporter-2 inhibitors: Use in patients with chronic kidney disease
Jamie Falk, Scott Klarenbach, Cynthia Lam, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 14, 2023
Continuous glucose monitoring in diabetes
Samantha S Moe, Michael R Kolber, Jamie Falk
Canadian Family Physician Medecin De Famille Canadien
|
June 17, 2024
Medications for apathy in dementia
Jen Potter, Wyatt Baloun, Bradley LeDrew, et al.
Canadian Family Physician Medecin De Famille Canadien
|
October 14, 2022
Jamie Falk, Scott Klarenbach, Cynthia Lam, et al.
Canadian Family Physician Medecin De Famille Canadien
|
December 14, 2022
Antibiotic prophylaxis for urinary tract infection
Caitlin R Finley, Jamie Falk, Christina S Korownyk
Canadian Family Physician Medecin De Famille Canadien
|
January 23, 2024
ASA use in patients at risk of preeclampsia
Brianne Desrochers, Sasha Katwaroo, Karen Toews, et al.
Canadian Family Physician Medecin De Famille Canadien
|
March 17, 2026
Mirabegron for overactive bladder
Jamie Falk, Justin Lane, Taehoon Kim, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 12, 2023
Risk of muscle symptoms while taking statins
Jamie Falk, Allison Paige, Nicolas Dugré, et al.
Canadian Family Physician Medecin De Famille Canadien
|
March 18, 2024
Orexin antagonists for insomnia
Jennifer Young, Erin Lee, Adrienne J Lindblad, et al.
Canadian Journal of Diabetes
|
August 6, 2022
Potential Overtreatment and Overtesting Among Older Adults With Type 2 Diabetes Across Canada: An Observational, Retrospective Cohort Study
Sai Krishna Gudi, Shawn Bugden, Alexander Singer, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Canadian Family Physician Medecin De Famille Canadien
|
October 14, 2022
Sodium-glucose cotransporter-2 inhibitors: Use in patients with chronic kidney disease
Jamie Falk, Scott Klarenbach, Cynthia Lam, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 14, 2023
Continuous glucose monitoring in diabetes
Samantha S Moe, Michael R Kolber, Jamie Falk
Canadian Family Physician Medecin De Famille Canadien
|
June 17, 2024
Medications for apathy in dementia
Jen Potter, Wyatt Baloun, Bradley LeDrew, et al.
Canadian Family Physician Medecin De Famille Canadien
|
October 14, 2022
Jamie Falk, Scott Klarenbach, Cynthia Lam, et al.
Canadian Family Physician Medecin De Famille Canadien
|
December 14, 2022
Antibiotic prophylaxis for urinary tract infection
Caitlin R Finley, Jamie Falk, Christina S Korownyk
Canadian Family Physician Medecin De Famille Canadien
|
January 23, 2024
ASA use in patients at risk of preeclampsia
Brianne Desrochers, Sasha Katwaroo, Karen Toews, et al.
Canadian Family Physician Medecin De Famille Canadien
|
March 17, 2026
Mirabegron for overactive bladder
Jamie Falk, Justin Lane, Taehoon Kim, et al.
Canadian Family Physician Medecin De Famille Canadien
|
May 12, 2023
Risk of muscle symptoms while taking statins
Jamie Falk, Allison Paige, Nicolas Dugré, et al.
Canadian Family Physician Medecin De Famille Canadien
|
March 18, 2024
Orexin antagonists for insomnia
Jennifer Young, Erin Lee, Adrienne J Lindblad, et al.
Canadian Journal of Diabetes
|
August 6, 2022
Potential Overtreatment and Overtesting Among Older Adults With Type 2 Diabetes Across Canada: An Observational, Retrospective Cohort Study
Sai Krishna Gudi, Shawn Bugden, Alexander Singer, et al.
Page
of 7